Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Juan,Du ^[1] ; Linxi,Zhu ^[2] ; Huizi,Sha ^[1] ; Zhengyun,Zou ^[1] ; Jie,Shen ^[1] ; Weiwei,Kong ^[1] ; Lianjun,Zhao ^[1] ; Qing,Gu ^[3] ; Lixia,Yu ^[1] ; Yudong,Qiu ^[2] ; Baorui,Liu ^[1]

作者单位： The Comprehensive Cancer Center of Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China. ^[1] Department of Hepatopancreatobiliary Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China. ^[2] National Institute of Healthcare Data Science, Nanjing University, Nanjing, China. ^[3]

关键词 Adverse effect BRCA1 mRNA Immunotherapy Individualized chemotherapy Pancreatic cancer

DOI 10.3389/fonc.2022.1015232

PMID 36387089

发布时间 2022-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

1015232页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除